Cargando…
Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity
Quercetin (3,5,7,3′,4′-pentahydroxyflavone) is a flavone with putative ability to prevent cancer and cardiovascular diseases. Its metabolism was evaluated in rats and human. Rats received quercetin via the intravenous (i.v.) route and metabolites were isolated from the plasma, urine and bile. Analys...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747694/ https://www.ncbi.nlm.nih.gov/pubmed/15292928 http://dx.doi.org/10.1038/sj.bjc.6602091 |
_version_ | 1782172116649508864 |
---|---|
author | Jones, D J L Lamb, J H Verschoyle, R D Howells, L M Butterworth, M Lim, C K Ferry, D Farmer, P B Gescher, A J |
author_facet | Jones, D J L Lamb, J H Verschoyle, R D Howells, L M Butterworth, M Lim, C K Ferry, D Farmer, P B Gescher, A J |
author_sort | Jones, D J L |
collection | PubMed |
description | Quercetin (3,5,7,3′,4′-pentahydroxyflavone) is a flavone with putative ability to prevent cancer and cardiovascular diseases. Its metabolism was evaluated in rats and human. Rats received quercetin via the intravenous (i.v.) route and metabolites were isolated from the plasma, urine and bile. Analysis was by high-performance liquid chromatography and confirmation of species identity was achieved by mass spectrometry. Quercetin and isorhamnetin, the 3′-O-methyl analogue, were found in both the plasma and urine. In addition, several polar peaks were characterised as sulphated and glucuronidated conjugates of quercetin and isorhamnetin. Extension of the metabolism studies to a cancer patient who had received quercetin as an i.v. bolus showed that (Quercetin removed) isorhamnetin and quercetin 3′-O-sulphate were major plasma metabolites. As a catechol, quercetin can potentially be converted to a quinone and subsequently conjugated with glutathione (GSH). Oxidation of quercetin with mushroom tyrosinase in the presence of GSH furnished GSH conjugates of quercetin, two mono- and one bis-substituted conjugates. However, these species were not found in biomatrices in rats treated with quercetin. As cyclo-oxygenase-2 (COX-2) expression is mechanistically linked to carcinogenesis, we examined whether quercetin and its metabolites can inhibit COX-2 in a human colorectal cancer cell line (HCA-7). Isorhamnetin and its 4′-isomer tamarixetin were potent inhibitors, reflected in a 90% decrease in prostaglandin E-2 (PGE-2) levels, a marker of COX-2 activity. Quercetin was less effective, with a 50% decline. Quercetin 3- and 7-O-sulphate had no effect on PGE-2. The results indicate that quercetin may exert its pharmacological effects, at least in part, via its metabolites. |
format | Text |
id | pubmed-2747694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-27476942009-09-21 Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity Jones, D J L Lamb, J H Verschoyle, R D Howells, L M Butterworth, M Lim, C K Ferry, D Farmer, P B Gescher, A J Br J Cancer Experimental Therapeutics Quercetin (3,5,7,3′,4′-pentahydroxyflavone) is a flavone with putative ability to prevent cancer and cardiovascular diseases. Its metabolism was evaluated in rats and human. Rats received quercetin via the intravenous (i.v.) route and metabolites were isolated from the plasma, urine and bile. Analysis was by high-performance liquid chromatography and confirmation of species identity was achieved by mass spectrometry. Quercetin and isorhamnetin, the 3′-O-methyl analogue, were found in both the plasma and urine. In addition, several polar peaks were characterised as sulphated and glucuronidated conjugates of quercetin and isorhamnetin. Extension of the metabolism studies to a cancer patient who had received quercetin as an i.v. bolus showed that (Quercetin removed) isorhamnetin and quercetin 3′-O-sulphate were major plasma metabolites. As a catechol, quercetin can potentially be converted to a quinone and subsequently conjugated with glutathione (GSH). Oxidation of quercetin with mushroom tyrosinase in the presence of GSH furnished GSH conjugates of quercetin, two mono- and one bis-substituted conjugates. However, these species were not found in biomatrices in rats treated with quercetin. As cyclo-oxygenase-2 (COX-2) expression is mechanistically linked to carcinogenesis, we examined whether quercetin and its metabolites can inhibit COX-2 in a human colorectal cancer cell line (HCA-7). Isorhamnetin and its 4′-isomer tamarixetin were potent inhibitors, reflected in a 90% decrease in prostaglandin E-2 (PGE-2) levels, a marker of COX-2 activity. Quercetin was less effective, with a 50% decline. Quercetin 3- and 7-O-sulphate had no effect on PGE-2. The results indicate that quercetin may exert its pharmacological effects, at least in part, via its metabolites. Nature Publishing Group 2004-09-13 2004-08-03 /pmc/articles/PMC2747694/ /pubmed/15292928 http://dx.doi.org/10.1038/sj.bjc.6602091 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Experimental Therapeutics Jones, D J L Lamb, J H Verschoyle, R D Howells, L M Butterworth, M Lim, C K Ferry, D Farmer, P B Gescher, A J Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity |
title | Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity |
title_full | Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity |
title_fullStr | Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity |
title_full_unstemmed | Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity |
title_short | Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity |
title_sort | characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity |
topic | Experimental Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747694/ https://www.ncbi.nlm.nih.gov/pubmed/15292928 http://dx.doi.org/10.1038/sj.bjc.6602091 |
work_keys_str_mv | AT jonesdjl characterisationofmetabolitesoftheputativecancerchemopreventiveagentquercetinandtheireffectoncyclooxygenaseactivity AT lambjh characterisationofmetabolitesoftheputativecancerchemopreventiveagentquercetinandtheireffectoncyclooxygenaseactivity AT verschoylerd characterisationofmetabolitesoftheputativecancerchemopreventiveagentquercetinandtheireffectoncyclooxygenaseactivity AT howellslm characterisationofmetabolitesoftheputativecancerchemopreventiveagentquercetinandtheireffectoncyclooxygenaseactivity AT butterworthm characterisationofmetabolitesoftheputativecancerchemopreventiveagentquercetinandtheireffectoncyclooxygenaseactivity AT limck characterisationofmetabolitesoftheputativecancerchemopreventiveagentquercetinandtheireffectoncyclooxygenaseactivity AT ferryd characterisationofmetabolitesoftheputativecancerchemopreventiveagentquercetinandtheireffectoncyclooxygenaseactivity AT farmerpb characterisationofmetabolitesoftheputativecancerchemopreventiveagentquercetinandtheireffectoncyclooxygenaseactivity AT gescheraj characterisationofmetabolitesoftheputativecancerchemopreventiveagentquercetinandtheireffectoncyclooxygenaseactivity |